IBIO
Income statement / Annual
Last year (2024), iBio, Inc.'s total revenue was $225,000.00,
and the percentage change from the previous year is not available.
In 2024, iBio, Inc.'s net income was -$24.91 M.
See iBio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$225,000.00
|
$0.00
|
$2.38 M
|
$2.37 M
|
$1.64 M
|
$2.02 M
|
$444,000.00
|
$394,000.00
|
$948,000.00
|
$1.85 M
|
| Cost of Revenue |
$1.25 M |
$1.11 M |
$216,000.00 |
$1.46 M |
$703,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$1.03 M |
-$1.11 M |
$2.17 M |
$909,000.00 |
$935,000.00 |
$2.02 M |
$444,000.00 |
$394,000.00 |
$948,000.00 |
$1.85 M |
| Gross Profit Ratio |
-4.56 |
0 |
0.91 |
0.38 |
0.57 |
1 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$5.19 M
|
$10.33 M
|
$17.73 M
|
$9.99 M
|
$3.21 M
|
$5.47 M
|
$3.99 M
|
$4.12 M
|
$3.16 M
|
$3.50 M
|
| General & Administrative
Expenses |
$11.67 M
|
$19.02 M
|
$34.13 M
|
$22.03 M
|
$12.43 M
|
$12.33 M
|
$10.69 M
|
$10.55 M
|
$7.69 M
|
$5.02 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$11.67 M
|
$19.02 M
|
$34.13 M
|
$22.03 M
|
$12.43 M
|
$12.33 M
|
$10.69 M
|
$10.55 M
|
$7.69 M
|
$5.02 M
|
| Other Expenses |
$0.00 |
$0.00 |
$13,000.00 |
$12,000.00 |
$10,000.00 |
$16,000.00 |
$19,000.00 |
$25,000.00 |
$21,000.00 |
$32,000.00 |
| Operating Expenses |
$16.86 M |
$29.34 M |
$51.86 M |
$32.02 M |
$15.64 M |
$17.81 M |
$14.67 M |
$14.67 M |
$10.84 M |
$8.52 M |
| Cost And Expenses |
$16.86 M |
$29.34 M |
$52.07 M |
$33.48 M |
$15.64 M |
$17.81 M |
$14.67 M |
$14.67 M |
$10.84 M |
$8.52 M |
| Interest Income |
$363,000.00 |
$213,000.00 |
$178,000.00 |
$140,000.00 |
$15,000.00 |
$75,000.00 |
$15,000.00 |
$39,000.00 |
$22,000.00 |
$9,000.00 |
| Interest Expense |
$172,000.00 |
-$83,000.00 |
$1.41 M |
$2.45 M |
$2.47 M |
$1.90 M |
$1.92 M |
$1.93 M |
$807,000.00 |
$0.00 |
| Depreciation &
Amortization |
$1.25 M
|
$1.11 M
|
$3.79 M
|
$2.41 M
|
$2.24 M
|
$1.75 M
|
$1.71 M
|
$1.68 M
|
$940,000.00
|
$363,000.00
|
| EBITDA |
-$15.02 M
|
-$29.31 M
|
-$45.71 M
|
-$30.96 M
|
-$11.74 M
|
-$13.95 M
|
-$12.48 M
|
-$12.53 M
|
-$8.91 M
|
-$6.30 M
|
| EBITDA Ratio |
-66.76 |
0 |
-19.18 |
-13.06 |
-7.17 |
-6.91 |
-28.12 |
-31.81 |
-9.4 |
-3.41 |
| Operating Income Ratio
|
-73.93
|
0
|
-20.85
|
-13.12
|
-8.55
|
-7.82
|
-32.04
|
-36.23
|
-10.44
|
-3.6
|
| Total Other
Income/Expenses Net |
$1.00 M
|
-$533,000.00
|
-$614,000.00
|
$7.90 M
|
-$2.44 M
|
-$1.81 M
|
$19,000.00
|
$25,000.00
|
$21,000.00
|
$32,000.00
|
| Income Before Tax |
-$15.44 M |
-$29.31 M |
-$50.30 M |
-$23.21 M |
-$16.44 M |
-$17.60 M |
-$16.11 M |
-$16.14 M |
-$10.66 M |
-$6.63 M |
| Income Before Tax Ratio
|
-68.64
|
0
|
-21.11
|
-9.79
|
-10.04
|
-8.72
|
-36.28
|
-40.96
|
-11.24
|
-3.58
|
| Income Tax Expense |
$9.64 M |
-$1.64 M |
$701,000.00 |
$46,000.00 |
$2.47 M |
-$4,000.00 |
$34,000.00 |
$347,000.00 |
-$65,000.00 |
-$9,000.00 |
| Net Income |
-$24.91 M |
-$29.31 M |
-$51.01 M |
-$23.26 M |
-$18.92 M |
-$17.59 M |
-$16.11 M |
-$14.53 M |
-$9.76 M |
-$6.63 M |
| Net Income Ratio |
-110.7 |
0 |
-21.4 |
-9.81 |
-11.55 |
-8.72 |
-36.27 |
-36.88 |
-10.3 |
-3.58 |
| EPS |
-6.5 |
-47.87 |
-116.97 |
-59.45 |
-150.61 |
-70.5 |
-37.87 |
-40.77 |
-30.15 |
-23.17 |
| EPS Diluted |
-6.5 |
-47.87 |
-116.97 |
-59.45 |
-150.61 |
-70.5 |
-37.87 |
-40.77 |
-30.15 |
-23.17 |
| Weighted Average Shares
Out |
$3.83 M
|
$612,250.00
|
$436,050.00
|
$391,250.00
|
$125,590.00
|
$249,537.00
|
$425,239.00
|
$356,440.00
|
$323,892.00
|
$285,980.00
|
| Weighted Average Shares
Out Diluted |
$3.83 M
|
$612,250.00
|
$436,050.00
|
$391,250.00
|
$125,590.00
|
$249,537.00
|
$425,240.00
|
$356,440.00
|
$323,892.00
|
$285,980.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
